ABSTRACT Alzheimer’s disease and cognitive decline are increasingly understood as complex, multifactorial processes influenced by far more than amyloid plaques and tau pathology alone. Metabolic dysfunction, insulin resistance, chronic inflammation, vascular health, impaired cerebral energetics, nutrition, sleep and glymphatic function, physical inactivity, chronic stress, environmental influences, and the physiological changes of aging may all contribute to the neurological environment in which cognitive decline develops and progresses.
A Comprehensive Approach to Cognitive Decline and Alzheimer’s Disease Treating the Whole Patient
Drawing upon contemporary research and more than fifty years of clinical experience, Gregory T. Lawton, D.C., D.N., D.Ac., N.D., presents a comprehensive whole-patient approach to cognitive health. This monograph explores Mediterranean and modified ketogenic nutrition, metabolic and inflammatory regulation, exercise, restorative sleep, nutritional and botanical support, cannabinoid therapy, stress management, and cognitive and social engagement, with an emphasis on early recognition, individualized intervention, and preserving neurological function, independence, resilience, and quality of life.
Dr. Gregory Lawton
A Comprehensive Approach to Cognitive Decline and Alzheimer’s Disease – Treating the Whole Patient Metabolism, Inflammation, Nutrition, Sleep, Movement, and the Whole-Patient Approach to Cognitive Health Gregory T. Lawton, D.C., D.N., D.Ac., N.D. Health Science Writer, Educator, and Clinician Blue Heron Academy American Health Source 2026
1|Pa ge
Copyright © 2026 Gregory T. Lawton, D.C., D.N., D.Ac., N.D. All rights reserved. No portion of this publication may be reproduced, distributed, transmitted, stored in a retrieval system, or used in any form or by any means without the written permission of the author, except for brief quotations used for educational, scholarly, or review purposes as permitted by law. Published for educational purposes by Blue Heron Academy and American Health Source. This publication is intended for professional education and general informational purposes. It is not intended to diagnose disease, prescribe treatment, or replace individualized medical evaluation or care. Cognitive decline may result from numerous neurological, metabolic, vascular, psychiatric, nutritional, medication-related, and other medical conditions. Individuals experiencing new or progressive cognitive symptoms should receive appropriate medical evaluation. Discussion of nutritional approaches, dietary supplements, botanical medicines, cannabinoids, and other therapeutic interventions is provided for educational purposes and should not be interpreted as a recommendation for treatment of any individual. Clinical decisions should consider the patient's diagnosis, medications, health history, age, individual risk factors, applicable laws and regulations, and the available scientific evidence. First Edition, 2026 Gregory T. Lawton Blue Heron Academy American Health Source
2|Pa ge
Preface During more than fifty years of clinical practice, teaching, and health science writing, I have witnessed profound changes in the way health professionals understand chronic disease. Again and again, conditions once approached primarily as isolated diseases of individual organs have proven to be influenced by broader relationships involving metabolism, inflammation, circulation, nutrition, physical activity, sleep, stress, environmental exposure, and the changing physiology of aging. Cognitive decline and Alzheimer’s disease deserve the same breadth of consideration. For many years, much of the public discussion surrounding Alzheimer’s disease centered upon beta-amyloid plaques and tau tangles. These remain important features of the disease and continue to be major areas of scientific investigation. Yet they do not exist independently of the person in whom they develop. The brain is nourished by the foods we consume, supplied by the cardiovascular system, regulated by metabolic and endocrine processes, affected by inflammatory signaling, restored during sleep, stimulated by movement and learning, and influenced throughout life by our physical and social environments. My clinical approach has therefore been to ask a broader question: What conditions within the patient may be contributing to neurological dysfunction, and which of those conditions can reasonably be changed? That question leads naturally to the subjects explored in this publication: metabolic syndrome, insulin resistance, obesity, chronic inflammation, vascular health, nutrition, therapeutic ketosis, exercise, restorative sleep, sleep apnea, glymphatic function, stress management, nutritional supplementation, botanical medicine, cannabinoid therapy, environmental influences, and cognitive and social engagement. This approach does not depend upon the belief that a single dietary program, supplement, herb, medication, or alternative therapy can cure Alzheimer’s disease. Quite the opposite. It begins with the recognition that cognitive decline is complex and that complex disorders frequently require us to examine multiple interacting physiological systems.
3|Pa ge
Clinical experience is important, but it must remain in conversation with scientific investigation. Some interventions discussed in these pages are supported by substantial human evidence. Others are supported by emerging clinical research, physiological mechanisms, preliminary trials, or clinical observations that require further investigation. These distinctions are important and should be respected. The purpose of this publication is therefore neither to reject conventional neurological medicine nor to promote an alternative doctrine. Its purpose is to encourage a more comprehensive clinical perspective, one in which the neurological patient is understood as a whole person and in which every reasonable opportunity to improve health, function, resilience, and quality of life is carefully considered. Gregory T. Lawton, D.C., D.N., D.Ac., N.D. 2026
4|Pa ge
Introduction Alzheimer’s disease is one of the most challenging health problems associated with aging. Its effects extend far beyond memory loss. Progressive cognitive impairment can alter communication, judgment, orientation, personality, mobility, independence, family relationships, and eventually the ability to perform the ordinary activities of daily living. The consequences are experienced not only by the individual but also by spouses, families, caregivers, health professionals, and communities. For decades, the dominant biological description of Alzheimer’s disease has emphasized the accumulation of beta-amyloid plaques outside neurons and abnormal forms of tau within neurons. These pathological findings remain central to the diagnosis and scientific investigation of Alzheimer’s disease. The development of biomarkers capable of detecting amyloid and phosphorylated tau has further strengthened our ability to identify the biological processes associated with the disease, sometimes before dementia becomes clinically apparent. Yet identifying pathology is not the same as completely explaining why that pathology develops or progresses. The aging brain exists within an extraordinarily complex biological environment. It requires a continuous supply of oxygen and nutrients, enormous quantities of cellular energy, effective vascular regulation, appropriate glucose metabolism, balanced inflammatory responses, restorative sleep, efficient waste-clearance mechanisms, adequate nutritional status, and continuing neurological stimulation. Disturbances within any of these systems may affect neurological function, and several disturbances frequently occur simultaneously in older adults. This broader perspective is particularly important because many factors associated with cognitive health are potentially modifiable. Insulin resistance can be addressed. Metabolic syndrome can be treated. Excessive consumption of refined sugars and highly processed foods can be changed. Physical activity can be increased. Nutritional deficiencies can be identified. Sleep disorders, including obstructive sleep apnea, can be investigated and treated. Hypertension and other vascular risk factors can be managed. Chronic inflammatory sources can sometimes be identified. 5|Pa ge
Stress can be reduced. Social isolation can be addressed. Cognitive and physical stimulation can continue throughout aging. Sleep provides an excellent illustration of the interconnected nature of these processes. Restorative sleep influences memory, glucose metabolism, hormonal regulation, cardiovascular function, immune activity, and emotional health. Sleep also interacts with the glymphatic system, a physiological pathway involved in cerebrospinal and interstitial fluid exchange and the clearance of metabolic waste products from the central nervous system. Research into glymphatic function has added another dimension to our understanding of why chronic sleep disruption may be particularly important in the aging brain. Nutrition provides another example. A Mediterranean-style dietary pattern may simultaneously influence cardiovascular health, glucose regulation, inflammation, nutrient status, body composition, and gastrointestinal health. In selected patients, a modified ketogenic intervention may provide an alternative source of cerebral energy while metabolic dysfunction is being addressed. These approaches need not be regarded as competing diets but can instead represent different components or phases of an individualized nutritional strategy. The same principle applies to exercise. Physical activity is not simply a method of burning calories. Aerobic exercise, resistance training, balance exercises, Tai Chi Chuan, and other coordinated forms of movement can influence cardiovascular function, insulin sensitivity, muscle mass, mitochondrial activity, sleep, mood, balance, proprioception, and neurological stimulation simultaneously. Emerging therapies also deserve careful investigation. Botanical medicines, targeted nutritional supplementation, cannabinoids, and other interventions should neither be accepted uncritically nor dismissed simply because they fall outside older therapeutic models. Their appropriate place should be determined by the quality of available evidence, biological plausibility, clinical observation, patient response, safety, and continuing research. This publication therefore approaches cognitive decline from the perspective of physiological interconnection. Metabolism cannot be completely separated from inflammation. Inflammation cannot be separated 6|Pa ge
from vascular function. Vascular function influences cerebral energetics. Sleep influences metabolism, cognition, and neurological clearance mechanisms. Exercise affects nearly all of these systems. Nutrition influences them as well. The purpose of a comprehensive approach is not to claim that every case of cognitive decline can be prevented or reversed. Nor is it to replace appropriate neurological diagnosis, biomarker testing, imaging, medication, or specialist care. The purpose is to recognize that a diagnosis does not eliminate the importance of everything else occurring within the patient. The chapters that follow examine these interconnected factors and consider how nutrition, metabolism, inflammation control, sleep restoration, physical activity, stress management, nutritional and botanical support, cannabinoid therapy, vascular health, and continued cognitive engagement may be incorporated into a broader strategy for preserving neurological function. The underlying principle is straightforward: when the brain is struggling, we should investigate and support the health of the entire person in whom that brain resides.
7|Pa ge
A Comprehensive Approach to Cognitive Decline and Alzheimer’s Disease - Treating the Whole Patient Our understanding of Alzheimer’s disease and cognitive decline continues to evolve. Rather than viewing Alzheimer’s disease solely as a disorder characterized by the accumulation of beta-amyloid plaques and tau tangles, a broader clinical model recognizes that cognitive decline develops within the complex physiology of the whole person. Metabolic dysfunction, chronic inflammation, vascular disease, impaired cerebral energetics, poor sleep, inadequate oxygenation, nutritional deficiencies, physical inactivity, chronic stress, environmental exposures, gastrointestinal and oral health, and other physiological disturbances may interact with genetic susceptibility and the biological processes associated with aging. This perspective does not require us to reject the importance of amyloid or tau. Instead, it encourages us to ask what conditions within the patient may be contributing to the development or progression of neurological dysfunction. The practical consequence is an approach that seeks not only to identify the manifestations of cognitive decline, but also to recognize and modify as many contributing physiological and lifestyle factors as reasonably possible. Cognitive Decline May Begin Years Before Dementia The pathological processes associated with Alzheimer’s disease may begin many years before dementia becomes clinically apparent. This potentially creates an important opportunity for prevention and early intervention. A patient may initially notice subtle changes in memory, concentration, word retrieval, orientation, mental endurance, or executive function while still performing normally on conventional cognitive testing. This period is commonly described as subjective cognitive decline or subjective cognitive impairment. Later, measurable cognitive deficits may become apparent while the individual remains largely capable of independent living. This is generally classified as mild cognitive impairment. Eventually, cognitive and functional deterioration may become sufficiently severe to interfere substantially with independent daily living and meet the clinical criteria for dementia.
8|Pa ge
The clinical objective should therefore not be limited to treating established dementia. Ideally, intervention begins when metabolic, inflammatory, vascular, nutritional, sleep-related, or cognitive changes first become apparent. The earlier potentially modifiable contributors are recognized, the greater the opportunity to preserve neurological function and overall health. Metabolic Health and the Brain Metabolic health should be considered one of the central components of any comprehensive approach to cognitive decline. Insulin resistance, metabolic syndrome, visceral obesity, hyperglycemia, dyslipidemia, and diabetes are associated with physiological processes capable of adversely affecting cerebral circulation, mitochondrial function, inflammatory signaling, and neuronal metabolism. Consequently, the assessment of a patient with cognitive decline should include careful consideration of metabolic function rather than focusing exclusively on neurological symptoms. Treatment should emphasize restoration of insulin sensitivity, improvement of body composition when appropriate, reduction of excessive refined carbohydrate intake, elimination or substantial reduction of processed and refined sugars, and improvement of overall metabolic flexibility. This is particularly important because metabolic dysfunction does not operate independently of other neurological risk factors. Insulin resistance and visceral adiposity can contribute to chronic inflammation, endothelial dysfunction, oxidative stress, vascular disease, and impaired cellular energy production. Improving metabolic health may therefore influence several neurological processes simultaneously. Nutrition, the Mediterranean Diet, and Therapeutic Ketosis A predominantly whole-food Mediterranean dietary pattern provides an excellent nutritional foundation for patients experiencing cognitive decline or attempting to reduce their future risk. Such a diet emphasizes vegetables, leafy greens, herbs and spices, berries and other appropriate fruits, nuts and seeds, legumes when metabolically tolerated, extra-virgin olive oil and other predominantly unsaturated fats, fish, and appropriate sources of protein. Highly processed foods, refined carbohydrates, excessive refined sugars, and foods that repeatedly produce large glycemic excursions should be substantially reduced or eliminated. 9|Pa ge
During the early stages of treatment, selected patients may benefit from a modified ketogenic approach. The purpose is not necessarily to maintain extreme nutritional ketosis indefinitely. Rather, mild nutritional ketosis may provide an alternative cerebral energy substrate during a period in which metabolic health and insulin sensitivity are being restored. This approach recognizes the potential value of ketones without requiring every patient to remain on a rigid ketogenic diet permanently. A reasonable long-term objective is metabolic flexibility within a predominantly Mediterranean dietary pattern. The patient should be able to maintain stable glucose regulation, appropriate body composition, adequate nutrient intake, and healthy lipid and cardiovascular parameters while avoiding the metabolic instability produced by excessive refined carbohydrate and sugar consumption. Chronic Inflammation Chronic inflammation represents another major therapeutic target. Persistent inflammatory signaling may arise from numerous sources, including visceral adiposity, insulin resistance, periodontal disease, chronic infection, gastrointestinal dysfunction, autoimmune activity, smoking, poor dietary patterns, inadequate sleep, chronic psychological stress, and environmental exposures. The clinical objective should not simply be to suppress inflammation. Whenever possible, the practitioner should attempt to determine why the patient is inflamed. Anti-inflammatory foods, herbs, nutrients, and medications may have therapeutic value, but a more comprehensive approach attempts to identify and reduce the underlying factors that are continually stimulating the inflammatory response. This is particularly relevant to cognitive decline because inflammation can affect vascular function, insulin signaling, mitochondrial activity, microglial behavior, and neuronal function. Metabolic dysfunction and inflammation therefore frequently reinforce one another rather than representing two separate problems. Amyloid as Biology and Pathology Beta-amyloid should not necessarily be understood only as an abnormal substance attacking the brain. Research has demonstrated antimicrobial 10 | P a g e
and innate immune properties of beta-amyloid, contributing to the hypothesis that amyloid production may, under some circumstances, participate in an initially protective response. This possibility has encouraged researchers to examine why amyloid is being produced and accumulated rather than considering its presence only as an isolated pathological event. The difficulty may arise when protective mechanisms become chronically activated, excessive, or inadequately regulated. Persistent amyloid accumulation can still participate in pathological processes involving neuroinflammation, synaptic dysfunction, tau pathology, and neuronal injury. The clinically useful lesson is therefore not that amyloid is either beneficial or harmful in every circumstance. Rather, it is that the physiological conditions encouraging persistent neurological stress and abnormal protein accumulation deserve investigation alongside the amyloid itself. Cerebral Energetics, Circulation, and Oxygenation The brain has enormous metabolic requirements and depends upon continuous delivery of oxygen and nutrients. Anything that chronically compromises cerebral blood flow, oxygen delivery, mitochondrial function, or energy availability may reduce neurological resilience. Cardiovascular disease, hypertension, hypotension, endothelial dysfunction, diabetes, physical inactivity, anemia, pulmonary disease, and sleep-disordered breathing therefore deserve attention when evaluating cognitive decline. Vascular health and brain health are intimately connected. Treatment should include appropriate evaluation and management of cardiovascular and cerebrovascular risk factors rather than separating the brain from the circulatory system that supports it. Maintaining appropriate blood pressure, vascular integrity, physical activity, oxygenation, and metabolic health should be considered part of neurological care. Sleep, the Glymphatic System, and Sleep Apnea Restorative sleep is fundamental to neurological health. Poor sleep affects memory consolidation, glucose regulation, hormonal balance, inflammatory signaling, emotional regulation, and daytime cognitive performance. Chronic sleep disruption may therefore contribute both directly and 11 | P a g e
indirectly to worsening cognitive function. An additional consideration is the relationship between sleep and the brain's glymphatic system. The glymphatic system is a fluid-transport and waste-clearance pathway within the central nervous system involving cerebrospinal fluid, interstitial fluid exchange, perivascular spaces, and astrocytes. Aquaporin-4 water channels located on astrocytic endfeet appear to play an important role in facilitating this movement of fluid through brain tissue. Through these mechanisms, the glymphatic system participates in the removal of metabolic waste products and potentially harmful proteins from the brain. Of relevance to Alzheimer's disease, experimental research has demonstrated glymphatic involvement in the clearance of beta-amyloid and tau. Sleep and the sleep-wake cycle appear to influence this process. Foundational animal research demonstrated substantially greater cerebrospinal and interstitial fluid exchange during sleep than during wakefulness, accompanied by increased clearance of beta-amyloid from the brain. Human research using neuroimaging and biomarker techniques has subsequently strengthened the evidence that sleep, cerebrospinal fluid dynamics, and clearance mechanisms are physiologically interconnected. The relationship, however, should not be oversimplified into the popular statement that the brain simply “washes itself” during sleep. Glymphatic physiology is more complex, and questions remain regarding exactly how sleep stages, body position, vascular pulsation, respiration, aging, aquaporin-4 function, and neurological disease influence clearance in humans. Nevertheless, impaired sleep and disruption of normal glymphatic function represent a biologically plausible connection between chronic sleep disturbance and neurodegenerative processes. This relationship may also become increasingly important with aging. Normal aging is associated with alterations in sleep architecture, vascular function, cerebrospinal fluid dynamics, and aquaporin-4 organization. These changes may reduce the efficiency of metabolic waste clearance and potentially contribute to an environment in which beta-amyloid, tau, inflammatory mediators, and other metabolic products accumulate more readily. Obstructive sleep apnea deserves particular attention within this context. Repeated episodes of nocturnal hypoxia, changes in intrathoracic pressure, 12 | P a g e
sleep fragmentation, sympathetic activation, and vascular stress may adversely affect both neurological function and the physiological processes that support cerebral fluid movement and waste clearance. Patients with cognitive decline should therefore be questioned about snoring, witnessed apnea, excessive daytime sleepiness, morning headaches, nocturnal awakening, and other indications of sleep-disordered breathing. Improving sleep consequently involves considerably more than recommending a certain number of hours in bed. The quality, continuity, timing, and architecture of sleep are important. Circadian rhythm, medications, alcohol, pain, nocturia, breathing disorders, anxiety, environmental factors, and other causes of fragmented sleep should be considered. From the perspective of cognitive health, restorative sleep should be regarded not merely as a period of inactivity but as an active physiological state supporting memory consolidation, metabolic regulation, neurological recovery, and the normal clearance processes of the brain. Exercise as Neurological Therapy Exercise should be regarded as an essential component of treatment rather than merely a general wellness recommendation. Regular aerobic activity supports cardiovascular conditioning, cerebral circulation, insulin sensitivity, mitochondrial health, and metabolic function. Resistance training helps preserve muscle mass, glucose disposal, bone health, physical function, and independence. Balance, coordination, and complex movement activities provide additional neurological stimulation. Tai Chi Chuan, walking, resistance exercise, appropriate aerobic conditioning, and other forms of coordinated physical activity can therefore contribute to a comprehensive neurological rehabilitation program. Movement practices requiring memory, sequencing, balance, proprioception, spatial awareness, and coordination may be particularly valuable because they challenge the brain and body simultaneously. Exercise also interacts positively with many other therapeutic objectives. Regular physical activity can improve sleep, stress regulation, body composition, glucose metabolism, cardiovascular function, mobility, confidence, and social participation. Its therapeutic effects therefore extend far beyond simply increasing physical fitness. 13 | P a g e
Stress Management, Purpose, and Social Connection Chronic psychological stress can affect sleep, autonomic balance, endocrine function, inflammatory signaling, dietary behavior, glucose regulation, and cardiovascular physiology. Stress management should consequently be incorporated into cognitive rehabilitation rather than treated as an unrelated lifestyle consideration. Meditation, breathing practices, Tai Chi, Chi Kung, yoga, time in nature, music, artistic activity, prayer or spiritual practice, and other appropriate methods may help patients develop greater physiological and emotional resilience. The method chosen should be appropriate to the individual and sufficiently enjoyable or meaningful that it can become part of everyday life. Social isolation should also be addressed. Human beings are neurologically, psychologically, and emotionally social organisms. Maintaining meaningful relationships, conversation, family involvement, purpose, creativity, service, and participation in community life may contribute to quality of life while providing continued cognitive and emotional stimulation. Nutritional Supplementation Nutritional supplementation should be individualized rather than indiscriminate. The objective is not to give the patient the largest possible collection of supplements marketed for memory or brain health. Nutritional therapy should instead attempt to identify deficiencies, insufficiencies, and metabolic requirements and correct them intelligently. Depending upon the individual patient, assessment may include vitamin B12, folate, vitamin D, iron status, thyroid function, homocysteine, glucose regulation, essential fatty acid intake, and other nutritional or metabolic factors. Dietary history should remain central to this evaluation because supplements should complement a nutrient-dense diet rather than substitute for one. Supplement selection should also take age, renal and hepatic function, medications, absorption, dietary intake, and potential interactions into consideration. More supplementation is not necessarily better supplementation. 14 | P a g e
Botanical Medicine Selected medicinal herbs may have an appropriate place within a comprehensive treatment program. Botanical agents may be chosen for specific therapeutic objectives involving inflammatory regulation, circulation, stress response, sleep, gastrointestinal health, metabolic function, or other identified physiological needs. As with nutritional supplementation, botanical medicine should be selective and purposeful. The important principle is not the number of herbs being administered but whether each botanical intervention addresses an identifiable therapeutic objective and is appropriate for the individual patient. Medication use, anticoagulant therapy, cardiovascular conditions, renal and hepatic function, and potential herb-drug interactions should be considered when botanical therapies are incorporated into the treatment of older adults. Cannabinoids, THC, and Cognitive Decline The endocannabinoid system participates in numerous aspects of neurological regulation, including modulation of neurotransmission, appetite, sleep, pain, immune activity, inflammatory signaling, and behavior. THC and other cannabinoids are therefore being investigated for neurological and neuropsychiatric applications, including symptoms associated with dementia. Clinical research has examined dronabinol, a pharmaceutical form of THC, for agitation associated with Alzheimer’s disease. Recent randomized controlled research has reported clinically meaningful reductions in agitation, adding to earlier observations suggesting that cannabinoid therapy may have value for selected behavioral symptoms associated with dementia. Somnolence remains an important potential adverse effect, particularly in older adults. Of clinical interest is the possible application of carefully selected microdose or low-dose THC for behavioral disturbances occurring later in the day, including the agitation, confusion, restlessness, and sleep disruption commonly associated with sundowning. Clinical observations have also suggested that some patients demonstrate improved 15 | P a g e
engagement, communication, sleep, and apparent cognitive function when very small doses are used appropriately. At present, controlled clinical evidence is stronger for the reduction of agitation and certain behavioral symptoms than it is for restoration of cognitive function itself. This distinction is important. Clinical observations of cognitive improvement are being reported and are valuable and deserve investigation. The therapeutic objective of low-dose cannabinoid treatment is not intoxication. When cannabinoids are considered, the principle should be to use the lowest effective dose and carefully observe the individual response. Cognition, alertness, balance, blood pressure, sleep, appetite, behavioral changes, and possible medication interactions should be monitored. Older adults can be particularly sensitive to THC, and dose, timing, formulation, previous cannabinoid exposure, individual metabolism, and concurrent medications can substantially alter the response. Cannabinoid therapy is therefore best understood as a potentially useful individualized component of a much larger therapeutic strategy rather than as a stand-alone treatment for Alzheimer’s disease. Oral and Gastrointestinal Health The oral cavity and gastrointestinal tract should not be ignored in neurological care. Periodontal disease can contribute to chronic systemic inflammatory burden, while gastrointestinal dysfunction may affect nutrient absorption, immune signaling, metabolism, and inflammatory activity. Appropriate dental care, periodontal assessment, adequate dietary fiber, plant diversity, and maintenance of gastrointestinal health therefore fit naturally within a systemic approach to cognitive decline. When gastrointestinal symptoms or malabsorption are present, these conditions deserve investigation rather than assuming that neurological health can be addressed independently of digestive and nutritional function. Environmental and Toxic Exposures Environmental exposures should be considered when the patient's history provides a reasonable basis for doing so. Potential concerns may include 16 | P a g e
occupational exposures, heavy metals, air pollution, pesticides, solvents, mold-related environments, and other toxicants. Testing should nevertheless be clinically directed rather than indiscriminate. The detection of a substance in the body does not automatically establish that it caused the patient's cognitive decline. Exposure history, dose, duration, biological plausibility, clinical findings, and the quality of available evidence should all be considered. The objective is to identify significant and modifiable environmental burdens without attributing neurological disease to an exposure merely because that exposure can be measured. Cognitive Stimulation and Neuroplasticity The brain retains a capacity for adaptation throughout life. Cognitive rehabilitation should therefore encourage patients to continue learning, problem solving, reading, writing, creating art, making music, engaging socially, and developing new skills rather than withdrawing from challenging activities because cognitive difficulties have begun. Activities integrating cognition with movement may be particularly useful. Dance, Tai Chi, martial arts forms, musical performance, and other coordinated activities require varying combinations of memory, spatial processing, balance, proprioception, attention, rhythm, sensory integration, and motor planning. The objective is not merely to exercise the body or to perform isolated mental exercises. A comprehensive approach continually challenges the nervous system to interact with its environment, solve problems, coordinate movement, communicate, create, learn, and adapt. A Comprehensive Clinical Approach A practical clinical approach to cognitive decline begins by identifying the metabolic, inflammatory, vascular, nutritional, neurological, sleep-related, behavioral, medication-related, and environmental factors that may be contributing to the individual patient's condition. Treatment then attempts to reduce modifiable burdens such as refined sugar, highly processed foods, sedentary behavior, smoking, excessive alcohol, unnecessary cognitively 17 | P a g e
impairing medications, sleep disruption, and identifiable sources of chronic inflammation. The next objective is restoration. Insulin sensitivity, nutritional status, gastrointestinal health, sleep, oxygenation, circulation, metabolic flexibility, and appropriate body composition should be improved whenever possible. Rehabilitation should simultaneously encourage aerobic activity, resistance exercise, balance and coordination training, cognitive stimulation, meaningful social interaction, stress-management practices, and appropriate nutritional, botanical, cannabinoid, and other therapeutic interventions. Finally, improvement must be maintained. Cognitive function, activities of daily living, metabolic markers, sleep, cardiovascular health, medications, nutritional status, and overall functional ability should be periodically reassessed. A comprehensive program should evolve as the patient's condition changes rather than remaining a fixed protocol. Treating the Patient, Not Simply the Plaque Perhaps the most important principle is that Alzheimer’s disease occurs within a person, not simply within a brain scan. Amyloid, tau, synaptic dysfunction, and neuronal degeneration remain important components of Alzheimer’s disease, but they exist within a much larger biological environment involving metabolism, inflammation, circulation, oxygenation, nutrition, sleep, movement, stress, social relationships, environmental exposures, genetics, and aging. The emerging model of cognitive care therefore moves beyond the search for a single cause or a single treatment. It seeks to identify the many physiological burdens that may be reducing neurological resilience and then systematically reduce those burdens while strengthening the patient's remaining capacity for metabolism, circulation, movement, cognition, adaptation, and repair. From this perspective, the central clinical question is not simply how we remove amyloid or manage dementia after it becomes severe. The larger question is what can be changed in the patient's physiology, lifestyle, and environment today that may help preserve neurological function and quality of life tomorrow 18 | P a g e
Conclusion Cognitive decline and Alzheimer’s disease are complex disorders that cannot be fully understood by examining a single abnormal protein, metabolic pathway, genetic factor, or therapeutic intervention in isolation. Amyloid and tau remain important features of Alzheimer’s disease, but they exist within a much larger physiological environment influenced by metabolism, inflammation, vascular health, mitochondrial function, nutrition, sleep, glymphatic clearance, physical activity, stress, environmental exposures, social engagement, and the many biological changes associated with aging. This broader understanding changes the clinical question. Rather than waiting for cognitive impairment to become severe and then focusing primarily upon the manifestations of dementia, we should seek to identify potentially modifiable contributors as early as possible. Subjective cognitive changes and mild cognitive impairment may provide important opportunities to investigate metabolic dysfunction, insulin resistance, chronic inflammation, sleep disorders, vascular disease, nutritional deficiencies, medication effects, physical inactivity, and other conditions capable of reducing neurological resilience. Treatment should therefore be comprehensive, individualized, and directed toward improving the physiological environment in which the brain must function. A Mediterranean-based whole-food diet, elimination or substantial reduction of refined sugars and highly processed foods, appropriate use of therapeutic ketosis, regular aerobic and resistance exercise, restoration of healthy sleep, evaluation and treatment of sleep apnea, stress management, social and cognitive engagement, correction of nutritional deficiencies, selected botanical medicines, and carefully considered cannabinoid therapy may each address different aspects of this larger physiological picture. No single intervention should be expected to accomplish what a coordinated therapeutic program may achieve. The glymphatic system further illustrates how interconnected these processes are. Sleep, respiration, vascular pulsation, cerebrospinal fluid movement, and metabolic waste clearance are not isolated phenomena. Likewise, insulin resistance cannot be completely separated from inflammation, inflammation from vascular dysfunction, vascular dysfunction 19 | P a g e
from cerebral energetics, or cerebral energetics from neuronal function. The brain is inseparable from the physiology of the body that supports it. This approach also requires appropriate humility. Promising mechanisms and encouraging clinical observations should be distinguished from treatments that have already been established through controlled human research. At the same time, absence of definitive evidence should not prevent careful investigation of plausible interventions when they can be used responsibly, monitored appropriately, and integrated with established standards of care. Clinical observation can generate important questions, but those observations become most valuable when they encourage systematic research. Perhaps the most important principle is that the patient should never be reduced to a diagnosis, a cognitive test score, an MRI finding, or an amyloid biomarker. Behind every diagnosis is a person whose metabolic health, movement, sleep, nutrition, relationships, environment, emotional well-being, and sense of purpose continue to matter. The goal of a comprehensive approach is therefore larger than simply treating Alzheimer’s disease. It is to preserve function, independence, engagement, dignity, and quality of life for as long as possible while creating the healthiest physiological environment available to support the brain’s remaining capacity for adaptation and resilience. Early recognition gives us an opportunity. Comprehensive assessment gives us direction. Thoughtful intervention gives us something meaningful to do with both.
20 | P a g e
About the Author Gregory T. Lawton, D.C., D.N., D.Ac., N.D., is a health science writer, educator, and health care practitioner with more than 50 years of clinical and teaching experience in chiropractic, naprapathy, naturopathy, acupuncture, manual medicine, and holistic health care. Throughout his career, his clinical work and writing have emphasized an integrative approach to health that considers the complex relationships among nutrition, metabolism, inflammation, physical activity, stress, sleep, environmental influences, and the body's natural regulatory and restorative processes. Dr. Lawton is the founder of the Blue Heron Academy and American Health Source and has devoted much of his professional career to the education of health care practitioners and the development of clinical and continuing education programs. His health science writing reflects a lifelong interest in bringing together traditional healing knowledge, clinical experience, and contemporary scientific research in a practical and understandable form for health professionals and students. His approach to education encourages practitioners to look beyond isolated symptoms and diagnoses and to consider the whole person, the physiological environment in which illness develops, and the many modifiable factors that may influence health, function, resilience, and quality of life.
21 | P a g e
Selected References Bredesen DE, et al. Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications. Journal of Alzheimer's Disease. 2023. Toups K, et al. Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project. Journal of Alzheimer's Disease. 2022. Rosenberg PB, et al. A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease. American Journal of Geriatric Psychiatry. 2026;34(2):167-179. Cohen LM, et al. Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THCAD). International Psychogeriatrics. 2024;36(12):1245-1250. This material is intended for professional education and does not replace individualized medical evaluation, diagnosis, or treatment.
22 | P a g e